ES8601995A1 - Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas - Google Patents

Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas

Info

Publication number
ES8601995A1
ES8601995A1 ES531458A ES531458A ES8601995A1 ES 8601995 A1 ES8601995 A1 ES 8601995A1 ES 531458 A ES531458 A ES 531458A ES 531458 A ES531458 A ES 531458A ES 8601995 A1 ES8601995 A1 ES 8601995A1
Authority
ES
Spain
Prior art keywords
substd
opt
alkyl
alkoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531458A
Other languages
English (en)
Other versions
ES531458A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES531458A0 publication Critical patent/ES531458A0/es
Publication of ES8601995A1 publication Critical patent/ES8601995A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE S-TRIAZOLO 3,4-A FTALAZINAS, DE FORMULA (I), EN LA QUE R, R1, R2 Y R3 PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA CICLACION DEL CORRESPONDIENTE DERIVADO DE 4-SUSTITUIDA-1-HIDRAZINOFTALAZINA CON DISULFURO DE CARBONO; REACCION DE CLORACION OXIDANTE DE LA TRIAZOLO 3,4-A FTALAZINA OBTENIDA, DE FORMULA (I), EN LA QUE R Y TAMBIEN R1 PUEDEN SER MERCAPTO; Y DESPLAZAMIENTO DEL SUSTITUYENTE 3-CLORO Y/O 6-CLORO INTRODUCIDO, POR REACCION CON UNA AMINA. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES ANTIHIPERTENSORAS, ANTIINFLAMATORIAS, BRONCODILATADORA Y ANTICANCEROSA.
ES531458A 1982-01-18 1984-04-10 Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas Expired ES8601995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18

Publications (2)

Publication Number Publication Date
ES531458A0 ES531458A0 (es) 1985-11-01
ES8601995A1 true ES8601995A1 (es) 1985-11-01

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531458A Expired ES8601995A1 (es) 1982-01-18 1984-04-10 Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas

Country Status (20)

Country Link
US (1) US4788186A (es)
EP (1) EP0085840B1 (es)
JP (1) JPS58124786A (es)
KR (1) KR890000184B1 (es)
AT (1) ATE22562T1 (es)
AU (1) AU564026B2 (es)
CA (1) CA1214168A (es)
DE (1) DE3366494D1 (es)
DK (1) DK163145C (es)
ES (1) ES8601995A1 (es)
FI (1) FI81350C (es)
GR (1) GR78442B (es)
HU (1) HU193033B (es)
IE (1) IE55032B1 (es)
IL (1) IL67697A (es)
NO (1) NO161674C (es)
NZ (1) NZ203021A (es)
PH (1) PH21834A (es)
PT (1) PT76107A (es)
ZA (1) ZA83224B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
EP0915877A1 (en) * 1996-07-25 1999-05-19 MERCK SHARP & DOHME LTD. SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE
EA002436B1 (ru) * 1996-07-25 2002-04-25 Мерк Шарп Энд Домэ Лимитед Замещенные производные триазоло-пиридазина в качестве лигандов рецепторов гамк
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
WO1999025353A1 (en) * 1997-11-13 1999-05-27 Merck Sharp & Dohme Limited Therapeutic uses of triazolo-pyridazine derivatives
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
WO1999036423A1 (en) * 1998-01-14 1999-07-22 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
US6579875B1 (en) * 1998-01-21 2003-06-17 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
HUP0100647A3 (en) * 1998-02-25 2003-03-28 Merck Sharp & Dohme Ltd Hoddes Substituted 1,2,4-triazolo[3,4-a]pyridazine and its pharmaceutical use
BR9908155A (pt) 1998-02-25 2000-10-31 Merck Sharp & Dohme Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
AU1816900A (en) 1998-11-12 2000-05-29 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
WO2002083064A2 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. A method of treating cancer
EP1496981A2 (en) * 2002-04-08 2005-01-19 Merck & Co., Inc. Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
CA2578368C (en) * 2004-09-02 2013-07-02 Altana Pharma Ag Triazolophthalazines
BRPI0606379A2 (pt) * 2005-01-05 2009-06-23 Nycomed Gmbh triazolftalazinas
JP5130053B2 (ja) * 2005-01-05 2013-01-30 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
CN102791715B (zh) 2009-12-31 2016-04-27 卡洛斯三世国家癌症研究中心基金会 用作激酶抑制剂的三环化合物
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 Ｓ―トリアゾロ〔３，４ ―α〕〔５，６，７，８〕テトラヒドロ フタラジン類
GR70309B (es) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
IE55032B1 (en) 1990-05-09
ES531458A0 (es) 1985-11-01
NO161674B (no) 1989-06-05
KR840003254A (ko) 1984-08-20
FI81350B (fi) 1990-06-29
FI830100L (fi) 1983-07-19
PT76107A (en) 1983-02-01
FI81350C (fi) 1990-10-10
DK17983A (da) 1983-07-19
DK17983D0 (da) 1983-01-18
JPS58124786A (ja) 1983-07-25
CA1214168A (en) 1986-11-18
PH21834A (en) 1988-03-17
US4788186A (en) 1988-11-29
AU564026B2 (en) 1987-07-30
JPH048428B2 (es) 1992-02-17
NO161674C (no) 1989-09-13
DK163145C (da) 1992-06-22
KR890000184B1 (ko) 1989-03-09
IL67697A (en) 1990-02-09
ZA83224B (en) 1983-10-26
FI830100A0 (fi) 1983-01-12
IL67697A0 (en) 1983-05-15
ATE22562T1 (de) 1986-10-15
DK163145B (da) 1992-01-27
DE3366494D1 (de) 1986-11-06
AU1055083A (en) 1983-07-28
GR78442B (es) 1984-09-27
NZ203021A (en) 1986-05-09
EP0085840B1 (en) 1986-10-01
EP0085840A1 (en) 1983-08-17
HU193033B (en) 1987-08-28
NO830110L (no) 1983-07-19
IE830082L (en) 1983-07-18

Similar Documents

Publication Publication Date Title
ES8601995A1 (es) Un procedimiento para preparar s-triazolo(3, 4-a)ftalazinas
NO305365B1 (no) Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter
EG20267A (en) Process for preparing of substituted pyrimidine compounds and their use as pesticides
DE69835434D1 (de) Verwendung von colchinolderivate zur gefässschädigung
MY119254A (en) 1, 3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives
ES8607920A1 (es) Procedimiento para preparar nuevas bis-(4-aminofenil)-sulfo-nas substituidas
ES8602816A1 (es) Un procedimiento para la preparacion de nuevos antibioticos de cefalosporina.
FR2230366A1 (en) Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity
ES8500943A1 (es) Un procedimiento para preparar 1-triazolo(3,4-a)ftalazinas
BG104933A (en) Water soluble azoles and broad-spectrum antifungals
NO306296B1 (no) Substituerte kinolinderivater og deres anvendelse samt legemidler inneholdende derilvatene
ES8601987A1 (es) Un procedimiento para preparar derivados de acido 4,7-dihidropirazolo (3,4-b)piridin-5-carboxilico
ES8604894A1 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
BE815405A (en) Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity
FR2135740A5 (en) Herbicidal s-aryl arylamides
FR2164520A2 (en) 2-(n-heterocyclic amino)thiazolin-4-ones - with respiratory analeptic activity
AU606701B2 (en) Antipsychotic compositions containing dioxopiperidine derivatives
ES8604232A1 (es) Un procedimiento para la preparacion de derivados de penicilina
IT1093255B (it) Derivati fenossialcanolaminici
MY107787A (en) Therapeutic agents
IT1160302B (it) Derivati della 2-fenossimentil-morfolina
NL7900412A (en) 1-amino-2-hydroxy-3-phenoxy-3-phenyl-propane derivs. - useful as antidepressants
AU2003255646A1 (en) Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
IT1283574B1 (it) Uso di derivati beta-carbolinici come agenti antimetastatici
FR2269348A1 (en) 7-Acylamino cephalosporin derivs - antibacterials active against Gram positive and Gram negative bacteria

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303